All Updates

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.

Statement from Bryan Hannon, Chair of Tobacco Free Indiana INDIANAPOLIS, IN. – “Yesterday, the legislature did a big favor for Big Tobacco by passing legislation that will lower tax rates and maintain loopholes for some of the very products that the tobacco industry has used to addict Hoosier kids.

El Comité de Artes, Parques, Salud, Educación y Vecindarios de la Ciudad de Los Ángeles votó hoy a favor de avanzar un proyecto de ley que eliminaría la venta de los productos de tabaco aromatizados. La ordenanza ahora pasa al pleno del concejo para su consideración.

El Comité de Artes, Parques, Salud, Educación y Vecindarios de la Ciudad de Los Ángeles votó hoy a favor de avanzar un proyecto de ley que eliminaría la venta de los productos de tabaco aromatizados. La ordenanza ahora pasa al pleno del concejo para su consideración.

Wednesday marks six months since the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other new tobacco product manufacturers’ applications.

ACS CAN is joined by more than 65 organizations asking for colorectal screening to be included in the budget.

INDIANAPOLIS, IN. – Today, our elected officials worked to reduce the burden of cancer on Hoosier by passing House Bill 1238, which will eliminate cost sharing for all preventative colorectal cancer screenings, including follow-up colonoscopies after an abnormal stool-based test for most private insurance plans. “Colorectal cancer remains the second

The Iowa House on Monday approved House File 2412, which would require radon testing and mitigation in Iowa schools. The Gail Orcutt School Radon Safety Bill (named after a beloved retired teacher who died of radon-induced lung cancer) now heads to the Senate.

The American Cancer Society Cancer Action Network (ACS CAN) has been provided nearly one million dollars in support from Amgen for a pilot program to test a trial eligibility screening intervention intended to increase and diversify patient enrollment in cancer clinical trials.